Skip to main content

Advertisement

Table 3 Clinical characteristics of patients by group: Mean ± SD or number of patients and (%)

From: Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

Clinical characteristics All patients n = 219 CPG (+) n = 118 CPG (-) n = 101 p
Age (years) 60.4 ± 15.0 60.1 ± 15.3 60.7 ± 14.8 0.39
Sex (females) 121 (55.2%) 66 (56.0%) 55 (54.5%) 0.83
Previous cancer 32 (14.8%) 15 (12.8%) 17 (17.2%) 0.37
Tumour grade low (grade I) 38 (20.3%) 27 (27.6%) 11 (12.4%) 0.01
  intermediate (grade II) 38 (20.3%) 18 (18.3%) 20 (22.5%)  
  high (grade III) 70 (37.5%) 27 (27.6%) 43 (48.3%)  
  not applicable 41 (21.9%) 26 (26.5%) 15 (16.8%)  
Tumour site soft tissues 137 (62.6%) 71 (60.2%) 66 (65.4%) 0.43
  viscera 82 (37.4%) 47 (39.8%) 35 (34.6%)  
Tumour size in mm 94.6 ± 80.6 96.8 ± 91.4 91.9 ± 66.3 0.67
Tumour depth superficial 38 (18.9%) 22 (20.6%) 16 (17%) 0.52
depth deep 163 (81.1%) 85 (79.4%) 78 (83%)  
Histology GIST 54 (25.6%) 37 (32.5%) 17 (17.5%) 0.03
  Liposarcoma 45 (21.3%) 18 (15.8%) 27 (27.8%)  
  Leiomyosarcoma 25 (11.8%) 9 (7.9%) 16 (16.5%)  
  Sarcoma NOS 16 (7.6%) 9 (7.9%) 7 (7.2%)  
  Dermatofibrosarcoma 16 (7.6%) 11 (9.6%) 5 (5.2%)  
  Others 55 (26.1%) 30 (26.3%) 25 (25.8%)  
Relapse free survival (years) 2.40 2.46 2.16 0.04
  1. NOS: Not Otherwise Specified
  2. GIST: Gastro Intestinal Stromal Tumours